Takeshi Nagasaka
Department Kawasaki Medical School , Position Professor |
|
Language | English |
Title | Randomized phase III study of sequential treatment with capecitabine or 5-fluorouracil (FP) plus bevacizumab (BEV) followed by the addition with oxaliplatin (OX) versus initial combination with OX+FP+ BEV in the first-line chemotherapy for metastatic colorectal cancer: The C-cubed study |
Conference | ESMO Congress 2019 |
Conference Type | International society and overseas society |
Presentation Type | Poster notice |
Lecture Type | General |
Publisher and common publisher | ◎T. Nagasaka, R. Inada, H. Ojima, S. Noura, H. Tanioka, Y. Munemoto, Y. Shimada, K. Ishibashi, Y. Shindo, Y. Kagawa, A. Tomibayashi, K. Okamoto, A. Tsuji, Y. Tsuji, S. Yamaguchi, A. SAWAKI, H. Mishima, M. Shimokawa, M. Okajima, Y. Yamaguchi |
Date | 2019/09/29 |
Venue (city and name of the country) |
Barcelona, Spain |